Association between cholesterol efflux capacity and coronary restenosis after successful stent implantation

Heart and Vessels
Satoshi ImaizumiKeijiro Saku

Abstract

The measurement of high-density lipoprotein (HDL) functionality could be useful for identifying patients who have an increased risk of coronary restenosis after stent implantation. In the present study, we elucidates whether HDL functionality can predict restenosis. The participants included 48 consecutive patients who had stable angina and were successfully implanted with a drug-eluting stent (DES) or bare-metal stent. Follow-up coronary angiography was performed after 6-8 months of stenting. Cholesterol efflux and the anti-inflammatory capacity of HDL were measured before stenting (at baseline) and at follow-up. The mean age was 64 ± 11 years and the body mass index was 24 ± 3 kg/m(2). While HDL cholesterol (HDL-C) significantly increased from baseline to follow-up, there was no significant association between HDL-C level at baseline and in-stent late loss. Cholesterol efflux capacity was significantly increased from baseline to follow-up. The efflux capacity at baseline was negatively correlated with in-stent late loss, whereas the anti-oxidative activity of HDL at baseline was not associated with in-stent late loss. We analyzed the predictors of in-stent late loss using independent variables (efflux capacity and anti-oxidat...Continue Reading

References

Nov 18, 1998·The American Journal of Cardiology·P O Kwiterovich
Feb 24, 2001·Basic Research in Cardiology·L RössigA M Zeiher
Jun 19, 2001·Scandinavian Cardiovascular Journal : SCJ·O JohansenH Arnesen
Jul 16, 2005·Annals of Medicine·Mohamad NavabAlan M Fogelman
Nov 4, 2005·Circulation·Albert SchömigRainer Wessely
Mar 11, 2006·Arteriosclerosis, Thrombosis, and Vascular Biology·Colin TsoPhilip J Barter
Sep 12, 2007·Proceedings of the National Academy of Sciences of the United States of America·Naoki TerasakaAlan R Tall
Oct 19, 2007·Cleveland Clinic Journal of Medicine·Benjamin J Ansell
Oct 18, 2008·The Journal of Clinical Investigation·Naoki TerasakaAlan R Tall
Jan 14, 2011·The New England Journal of Medicine·Amit V KheraDaniel J Rader
Sep 14, 2011·Nature Reviews. Cardiology·J Wouter JukemaPaul H A Quax
Oct 1, 2011·Journal of Lipid Research·Theodoros KelesidisOtto O Yang
Feb 23, 2013·Heart and Vessels·Hidehiro KanekoTakeshi Yamashita
Mar 23, 2013·Arteriosclerosis, Thrombosis, and Vascular Biology·Xin-Min LiStanley L Hazen
Aug 13, 2013·Journal of the American College of Cardiology·Amit V KheraDaniel J Rader
Nov 19, 2014·The New England Journal of Medicine·Anand RohatgiPhilip W Shaul

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.